Bentoquatam
Trade name: Ivy Block
Small moleculeapproved
Approved
Aug 26, 1996
Bentonite is an absorbent swelling clay consisting mostly of montmorillonite which can either be Na-montmorillonite or Ca-montmorillonite. Na-montmorillonite has a considerably greater swelling capacity than Ca-montmorillonite. — Wikipedia
Clinical trial activity
0 trials · 0 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1990s
- Aug 26, 1996
Earliest FDA Approval
- Aug 26, 1996
Standard Homeopathic — Marketing Organization
- Aug 26, 1996
Standard Homeopathic — NDA Secondary Org
Indications
Approved for
Mechanism of action
- UnclearUnclear
Unclear unclear
Approval history
- approvedPriority reviewAug 26, 1996
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Over the Counter
Oral
No
Parenteral
No
Topical
Yes
Sources
- WikipediaBentonite ↗
- NCATS7F465U79Q1 ↗
- ChEMBLCHEMBL1201446 ↗
Also known as
- bentone 34
- bentoquatam
- bentoquatam
- bentoquatam
- bentoquatam
- bentoquatam
- bentoquatam
- bentoquatam
- bentoquatam
- dimethyldioctadecylammonium montmorillonite
- ivyblock
- ivy block
- ivy block
- ivy block
- ivy block
- quaternium 18-bentonite
Organizations
Marketing (3)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Standard Homeopathic | For profit | MKTG | Aug 26, 1996 |
| Standard Homeopathic | For profit | NDA2 | Aug 26, 1996 |
| United Catalysts | For profit | NDA | — |